JVTAX Mutual Fund

JVTAX Mutual Fund

NAV$87.73
See how much of JVTAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$29M
Expense Ratio
1.04%
Dividend Yield (Current)
-
Holdings
143
Inception Date
May 6, 2011
Fund Family
Janus Henderson Investors
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.30%
1 Year+9.09%
3 Year+17.73%
5 Year+2.29%
10 Year+10.01%

Asset Allocation

Stocks: 96.66%
Other: 3.34%
See how much of JVTAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
GKOSGlaukos Corp3.33%
LGNDLigand Pharmaceuticals Inc2.12%
PRMPerimeter Solutions Inc1.97%
SXTSensient Technologies Corp1.80%
SPXCSpx Corp1.79%
Top 10 Concentration: 19.33%Report Date: Aug 31, 2026
Download all 143 holdings for JVTAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$12.33
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

JVTAX Mutual Fund Overview

JVTAX Mutual Fund (Janus Henderson Venture Fund Class A) is managed by Janus Henderson Investors with $29.0M in net assets. JVTAX expense ratio is 1.04%, holding 143 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 2011-05-06.

JVTAX performance shows a YTD return of 7.30%. The 1-year return is 9.09% and the 5-year return is 2.29%.

JVTAX top holdings include Glaukos Corp (3.3%), Ligand Pharmaceuticals Inc (2.1%), Perimeter Solutions Inc (2.0%), Sensient Technologies Corp (1.8%), Spx Corp (1.8%). Go to all JVTAX holdings, JVTAX sectors, or JVTAX dividends.

JVTAX can be compared against other funds. Use JVTAX overlap to find shared positions, or JVTAX vs another fund for a side-by-side view. JVTAX alternatives are available via the screener, along with tax-loss harvesting opportunities.